BPC 157 acetate exhibits multiple activities such as promoting wound healing, tendon healing, neuroprotection, and gastrointestinal protection
The lethal dose threshold (LD1) was never achieved in animal safety studies meaning researchers could not identify a dose lethal to 1% of test subjects
GLP-1RA therapy inhibits glucagon secretion, at least transiently delays gastric emptying, and reduces appetite and food intake [60,61]
It signifies changes that are happening in your body and your lifechanges that can benefit from shifts in body and mind habits
2mL-4mL/500kg every second day or as directed by a veterinarian
Malhotra A, Grunstein RR, Fietze I, et al